Plain-English translation of NCT06200974 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing High Dose Rate (HDR) brachytherapy, a targeted radiation treatment delivered directly to the prostate in just two quick sessions about 1–2 weeks apart. Researchers want to understand exactly why this treatment works by studying changes in your blood, immune system, and gut bacteria before and after therapy. The goal is to learn whether fewer radiation sessions can be just as effective as the current standard treatment.
Over the past decade, doctors have shortened this treatment from multiple sessions down to a single dose, but the cure rate dropped from over 90% to about 65%. This trial exists to figure out what changed and whether the earlier sessions prepared the cancer to respond better to radiation—so doctors can make this treatment more effective while keeping it convenient for patients.
You likely qualify if…
You likely don't qualify if…
You will undergo two radiation treatment sessions under anesthesia, scheduled about 1–2 weeks apart, both done as an outpatient. Before your first treatment and again before your second treatment, doctors will take small tissue samples (biopsies) painlessly while you're under anesthesia. You'll also provide blood samples and possibly other samples (like a stool sample to study your gut bacteria) so researchers can track how your body responds to the radiation over time. Follow-up visits will monitor your PSA levels and treatment response for several years.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Canada